Skip to main content
Blood Cancer Journal logoLink to Blood Cancer Journal
. 2023 May 26;13(1):87. doi: 10.1038/s41408-023-00856-0

Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients

Rodrigo Fonseca 1, Mariano Arribas 1, Julia E Wiedmeier-Nutor 1, Yael N Kusne 1, Miguel González Vélez 2, Heidi E Kosiorek 3, Richard (Duke) J Butterfield 3, Ilan R Kirsch 4, Joseph R Mikhael 5, A Keith Stewart 6, Craig Reeder 1, Jeremy Larsen 1, P Leif Bergsagel 1, Rafael Fonseca 1,
PMCID: PMC10212911  PMID: 37230980

Correction to: Blood Cancer Journal 10.1038/s41408-023-00794-x, published online 06 March 2023

Following the publication of this article the authors noted and error in Figure 4, “Kaplan Meier curves for time to next treatment (TTNT) according to sequential MRD measurements”. The figure should have displayed only patients who had MRD taken at least 1 year apart (as defined by IMWG), but instead it incorrectly included an additional 8 patients with sequential measurements taken only at least 6 months apart.

The correct figure shows results based on the first MRD taken at least 1 year apart following day 100 evaluation, and should have appeared as below:graphic file with name 41408_2023_856_Fig1_HTML.jpg

The original article has been corrected.


Articles from Blood Cancer Journal are provided here courtesy of Nature Publishing Group

RESOURCES